Scholars@Duke
Journal cover image

Treatment of type III hyperlipoproteinemia.

Publication ,  Journal Article
Guyton, JR
Published in: Am Heart J
July 1999
Published version (DOI) Link to item

Duke Scholars

John Richard Guyton
Author John Richard Guyton Medicine, Endocrinology, Metabolism, and Nutrition

Published In

Am Heart J

DOI

10.1016/s0002-8703(99)70239-5

ISSN

0002-8703

Publication Date

July 1999

Volume

138

Issue

1 Pt 1

Start / End Page

17 / 18

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Simvastatin
  • Hypolipidemic Agents
  • Hyperlipoproteinemia Type III
  • Humans
  • Gemfibrozil
  • Cholesterol, VLDL
  • Cholesterol, LDL
  • Cardiovascular System & Hematology
  • Apolipoproteins E
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guyton, J. R. (1999). Treatment of type III hyperlipoproteinemia. Am Heart J, 138(1 Pt 1), 17–18. https://doi.org/10.1016/s0002-8703(99)70239-5
Guyton, J. R. “Treatment of type III hyperlipoproteinemia.” Am Heart J 138, no. 1 Pt 1 (July 1999): 17–18. https://doi.org/10.1016/s0002-8703(99)70239-5.
Guyton JR. Treatment of type III hyperlipoproteinemia. Am Heart J. 1999 Jul;138(1 Pt 1):17–8.
Guyton, J. R. “Treatment of type III hyperlipoproteinemia.” Am Heart J, vol. 138, no. 1 Pt 1, July 1999, pp. 17–18. Pubmed, doi:10.1016/s0002-8703(99)70239-5.
Guyton JR. Treatment of type III hyperlipoproteinemia. Am Heart J. 1999 Jul;138(1 Pt 1):17–18.
Journal cover image

Published In

Am Heart J

DOI

10.1016/s0002-8703(99)70239-5

ISSN

0002-8703

Publication Date

July 1999

Volume

138

Issue

1 Pt 1

Start / End Page

17 / 18

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Simvastatin
  • Hypolipidemic Agents
  • Hyperlipoproteinemia Type III
  • Humans
  • Gemfibrozil
  • Cholesterol, VLDL
  • Cholesterol, LDL
  • Cardiovascular System & Hematology
  • Apolipoproteins E